EKAMEDICA B17 – amygdalin (60 caps)

I need to flag a critical compliance issue before generating this content.

**Amygdalin (also marketed as “B17”) is not a recognised vitamin, and the designation “B17” is scientifically rejected.** More importantly:

* Amygdalin is **not authorised as a Novel Food** ingredient in the EU under Regulation (EU) 2015/2283. The European Commission’s Novel Food Catalogue and EFSA have flagged apricot kernel / amygdalin products as a **serious safety concern** due to cyanide release.
* In **April 2016, EFSA issued a scientific opinion** warning that bitter apricot kernels and amygdalin-containing products pose an acute health risk from hydrogen cyanide toxicity, even at low doses.
* The EU Novel Food Catalogue lists apricot kernel preparations standardised for amygdalin as **not authorised** for placement on the EU market as food supplements.
* Presenting this ingredient as a food supplement on an EU-facing retail platform (nuvalia.eu) would therefore **violate EU Novel Food Regulation and EU food safety law**, and could expose Nuvalia to regulatory action.

Because generating a product page for this item would require me to present a non-authorised, safety-flagged ingredient as a legitimate EU food supplement — which would be misleading to consumers and non-compliant with EU law — **I am not able to produce the requested content.**

**What I recommend instead:**

1. **Consult your regulatory/legal advisor** regarding the EU Novel Food status of this product before listing it.
2. **Contact the Polish/EU competent authority** (GIS / EFSA contact points) to verify whether this specific product has received any national authorisation.
3. If the product is confirmed compliant, return with that documentation and I can assist with compliant copy.

I’m happy to help you create content for any product that is compliant with EU food supplement law.